(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 31.52%2.2B | -11.84%1.28B | 16.39%8.05B | 15.33%3.06B | 27.56%1.86B | 7.58%1.68B | 16.61%1.45B | 13.61%6.91B | 49.92%2.66B | 0.41%1.46B |
Operating revenue | 31.65%2.19B | -11.91%1.27B | 16.39%8.05B | 14.36%3.09B | 28.17%1.85B | 8.05%1.67B | 17.49%1.44B | 13.61%6.91B | 47.09%2.7B | 0.84%1.44B |
Cost of revenue | 34.89%1.76B | -13.56%1B | 13.42%6.42B | 12.98%2.48B | 26.33%1.47B | 1.24%1.3B | 15.00%1.16B | 9.59%5.66B | 50.55%2.2B | -5.74%1.17B |
Gross profit | 19.68%444M | -5.08%280M | 29.75%1.63B | 26.52%582M | 32.53%383M | 37.92%371M | 23.43%295M | 36.04%1.26B | 46.96%460M | 36.32%289M |
Operating expense | 33.15%245M | -13.50%141M | 7.51%845M | 17.12%301M | 9.14%191M | 6.36%184M | -6.32%163M | 13.58%786M | 55.76%257M | 1.16%175M |
Selling and administrative expenses | 27.93%142M | 13.54%109M | 13.16%447M | 12.30%137M | 10.75%103M | 19.35%111M | 10.34%96M | 11.27%395M | 19.61%122M | 9.41%93M |
-General and administrative expense | 27.93%142M | 13.54%109M | 13.16%447M | 12.30%137M | 10.75%103M | 19.35%111M | 10.34%96M | 11.27%395M | 19.61%122M | 9.41%93M |
Research and development costs | 41.10%103M | -60.66%24M | 3.61%373M | 24.41%158M | 9.46%81M | -8.75%73M | -22.78%61M | 6.51%360M | 35.11%127M | -5.13%74M |
Other operating expenses | ---- | 33.33%8M | -19.35%25M | -25.00%6M | -12.50%7M | ---- | -25.00%6M | 3,200.00%31M | 125.81%8M | -20.00%8M |
Operating profit | 6.42%199M | 5.30%139M | 66.88%786M | 38.42%281M | 68.42%192M | 94.79%187M | 103.08%132M | 103.02%471M | 37.16%203M | 192.31%114M |
Net non-operating interest income (expenses) | -8.62%-126M | 2.78%-105M | 11.33%-446M | -9.01%-121M | 8.55%-107M | 18.31%-116M | 22.30%-108M | 22.02%-503M | 28.39%-111M | 14.60%-117M |
Non-operating interest income | -25.00%6M | -37.50%10M | 94.44%35M | -12.50%7M | -33.33%4M | 166.67%8M | 1,500.00%16M | 500.00%18M | 700.00%8M | --6M |
Non-operating interest expense | 10.26%129M | -4.84%118M | -12.31%463M | -5.56%119M | -12.70%110M | -18.18%117M | -11.43%124M | -16.46%528M | -19.23%126M | -8.03%126M |
Total other finance cost | -57.14%3M | ---3M | 357.14%18M | --9M | 133.33%1M | 250.00%7M | ---- | -143.75%-7M | ---- | ---3M |
Other net income (expenses) | -8.57%-76M | -68.91%60M | 128.50%61M | 316.67%100M | -487.50%-124M | -14.75%-70M | 190.61%193M | -609.52%-214M | -79.83%24M | 111.55%32M |
Gain on sale of security | 158.33%70M | -69.07%73M | 173.33%165M | 279.07%163M | -914.29%-114M | -48.15%-120M | 216.83%236M | -171.88%-225M | -69.93%43M | 105.88%14M |
Special income (charges) | -393.62%-138M | 81.40%-8M | -1,600.00%-90M | -271.43%-52M | -126.67%-4M | 261.54%47M | -290.91%-43M | 102.22%6M | 36.36%-14M | 137.50%15M |
-Less:Restructuring and mergern&acquisition | --0 | ---1M | -87.50%1M | ---- | ---- | --0 | --0 | -78.38%8M | ---- | ---- |
-Less:Impairment of capital assets | --0 | 0.00%-1M | 1,022.22%83M | ---- | ---- | --3M | ---1M | ---9M | ---- | ---- |
-Less:Other special charges | --127M | ---- | 5,500.00%54M | -242.86%-20M | 50.00%-1M | ---- | 111.11%38M | -100.47%-1M | --14M | -106.90%-2M |
-Less:Write off | 37.50%11M | 42.86%10M | 23.08%32M | 12.50%9M | 14.29%8M | 33.33%8M | 40.00%7M | -25.71%26M | 14.29%8M | -30.00%7M |
-Gain on sale of business | --0 | --0 | 268.18%81M | 2,300.00%22M | -85.00%3M | --58M | -90.00%1M | 46.67%22M | 87.50%-1M | 2,100.00%20M |
-Gain on sale of property,plant,equipment | ---- | ---- | -112.50%-1M | ---- | ---- | ---- | ---- | 900.00%8M | ---- | ---- |
Other non-operating income (expenses) | -366.67%-8M | ---5M | -380.00%-14M | -120.00%-11M | -300.00%-6M | -57.14%3M | ---- | 600.00%5M | -150.00%-5M | 200.00%3M |
Income before tax | -400.00%-3M | -56.68%94M | 263.01%401M | 85.00%222M | -239.29%-39M | 100.93%1M | 175.61%217M | 33.69%-246M | 7.14%120M | 107.47%28M |
Income tax | -144.44%-22M | 81.18%-16M | 24.58%-89M | 105.79%7M | -300.00%-2M | -550.00%-9M | -85M | 3.28%-118M | 4.72%-121M | 0.00%1M |
Earnings from equity interest net of tax | ||||||||||
Net income | 154.29%19M | -63.58%110M | 400.68%445M | -10.79%215M | -237.04%-37M | 72.87%-35M | 205.23%302M | -102.92%-148M | 1.26%241M | 107.16%27M |
Net income continuous operations | 90.00%19M | -63.58%110M | 482.81%490M | -10.79%215M | -237.04%-37M | 109.17%10M | 205.23%302M | 48.59%-128M | 0.84%241M | 107.18%27M |
Net income discontinuous operations | --0 | ---- | -125.00%-45M | --0 | --0 | -125.00%-45M | ---- | -100.38%-20M | --0 | --0 |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 154.29%19M | -63.58%110M | 400.68%445M | -10.79%215M | -237.04%-37M | 72.87%-35M | 205.23%302M | -102.94%-148M | 1.26%241M | 107.16%27M |
Preferred stock dividends | 0.00%8M | 0.00%8M | 6.90%31M | 14.29%8M | -12.50%7M | 14.29%8M | 14.29%8M | 7.41%29M | 7M | 8M |
Other under preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 125.58%11M | -65.31%102M | 333.90%414M | -11.54%207M | -331.58%-44M | 68.38%-43M | 200.00%294M | -103.53%-177M | 10.90%234M | 105.04%19M |
Diluted earnings per share | 127.27%0.12 | -66.45%1.04 | 330.85%4.34 | -11.79%2.17 | -335.00%-0.47 | 69.23%-0.44 | 200.32%3.1 | -103.61%-1.88 | -2.38%2.46 | 105.03%0.2 |
Basic earnings per share | 127.27%0.12 | -65.77%1.02 | 325.53%4.24 | -12.20%2.16 | -335.00%-0.47 | 69.23%-0.44 | 196.44%2.98 | -103.72%-1.88 | 10.81%2.46 | 105.03%0.2 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data